The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716
Abstract
BACKGROUND: SR141716, a recently developed CB1 cannabinoid receptor antagonist, blocks acute effects of Delta-9-tetrahydrocannabinol (THC) and other CB1 cannabinoid agonists in vitro and in animals. These findings suggest that CB1 receptors mediate many of the effects of marijuana, but this has not been evaluated in humans. METHODS: Sixty-three healthy men with a history of marijuana use were randomly assigned to receive oral SR141716 or a placebo in an escalating dose (1, 3, 10, 30, and 90 mg) design. Each subject smoked an active (2.64% THC) or placebo marijuana cigarette 2 hours later. Psychological effects associated with marijuana intoxication and heart rate were measured before and after antagonist and marijuana administration. RESULTS: Single oral doses of SR141716 produced a significant dose-dependent blockade of marijuana-induced subjective intoxication and tachycardia. The 90-mg dose produced 38% to 43% reductions in visual analog scale ratings of "How high do you feel now?" "How stoned on marijuana are you now?" and "How strong is the drug effect you feel now?" and produced a 59% reduction in heart rate. SR141716 alone produced no significant physiological or psychological effects and did not affect peak THC plasma concentration or the area under the time x concentration curve. SR141716 was well tolerated by all subjects. CONCLUSIONS: SR141716 blocked acute psychological and physiological effects of smoked marijuana without altering THC pharmacokinetics. These findings confirm, for the first time in humans, the central role of CB1 receptors in mediating the effects of marijuana.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
Giuffrida, A., Parsons, L. H., Kerr, T. M., de Fonseca, F. R., Navarro, M., & Piomelli, D. (1999) · Nature Neuroscience · doi:10.1038/7268 · Cited by 775
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 687
Arnone, M., Maruani, J., Chaperon, F., Thiébot, M.-H., Poncelet, M., Soubrié, P., & Fur, G. L. (1997) · Psychopharmacology · doi:10.1007/s002130050326 · Cited by 594
Cannabis: pharmacology and toxicology in animals and humans
ADAMS, I. B., & MARTIN, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 570
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors
Williams, C. M., & Kirkham, T. C. (1999) · Psychopharmacology · doi:10.1007/s002130050953 · Cited by 505
Elevated endogenous cannabinoids in schizophrenia
Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · NeuroReport · doi:10.1097/00001756-199906030-00008 · Cited by 432
Compton, D. R., Aceto, M. D., Lowe, J., & Martin, B. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357
Abstinence symptoms following smoked marijuana in humans
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050849 · Cited by 353
Di Marzo, V. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00042-3 · Cited by 312
Navarro, M., Hernández, E., Muñoz, R. M., del Arco, I., Villanúa, M. A., Carrera, M. R. A., & Rodríguez de Fonseca, F. (1997) · NeuroReport · doi:10.1097/00001756-199701200-00023 · Cited by 306
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Alonso, R., Shire, D., Congy, C., Soubrié, P., Brelière, J.-C., & Le Fur, G. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00174-5 · Cited by 303
Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
Terranova, J. P., Storme, J. J., Lafon, N., Pério, A., Rinaldi-Carmona, M., Le Fur, G., & Soubrié, P. (1996) · Psychopharmacology · doi:10.1007/bf02246352 · Cited by 283
CLINICAL STUDIES OF CANNABIS TOLERANCE AND DEPENDENCE*
Jones, R. T., Benowitz, N., & Bachman, J. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb49901.x · Cited by 270
SR141716A is an inverse agonist at the human cannabinoid CB1 receptor
Landsman, R. S., Burkey, T. H., Consroe, P., Roeske, W. R., & Yamamura, H. I. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01160-6 · Cited by 262
Abstinence symptoms following oral THC administration to humans
Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W. (1999) · Psychopharmacology · doi:10.1007/s002130050848 · Cited by 261
Cannabinoids, hippocampal function and memory
Hampson, R. E., & Deadwyler, S. A. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00294-5 · Cited by 221
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pessègue, B., Bonnin-Cabanne, O., Le Fur, G., Caput, D., & Ferrara, P. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00047-4 · Cited by 208
Comparative Effects of Alcohol and Marijuana on Mood, Memory, and Performance
Heishman, S. J., Arasteh, K., & Stitzer, M. L. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00456-x · Cited by 179
Self-citationCardiovascular effects of prolonged delta‐9‐tetrahydrocannabinol ingestion
Benowitz, N. L., & Jones, R. T. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975183287 · Cited by 168
Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal.
Aceto, M. D., Scates, S. M., Lowe, J. A., & Martin, B. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20781-9 · Cited by 168
Santucci, V., Storme, J.-J., Soubrié, P., & Le Fur, G. (1996) · Life Sciences · doi:10.1016/0024-3205(95)02319-4 · Cited by 165
Characterization of the absorption phase of marijuana smoking
Huestis, M. A., Sampson, A. H., Holicky, B. J., Henningfield, J. E., & Cone, E. J. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.100 · Cited by 164
Self-citationVásquez, C., & Lewis, D. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09271.1999 · Cited by 150
SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
Richardson, J. D., Aanonsen, L., & Hargreaves, K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00952-1 · Cited by 149
Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
Mansbach, R. S., Rovetti, C. C., Winston, E., & Lowe, J. A., III (1996) · Psychopharmacology · doi:10.1007/bf02247436 · Cited by 135
Cardiovascular effects of cannabinoids
Randall, M. D., Harris, D., Kendall, D. A., & Ralevic, V. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00258-9 · Cited by 132
Foltz, R. L., McGinnis, K., & Chinn, D. M. (1983) · Journal of Mass Spectrometry · doi:10.1002/bms.1200100503 · Cited by 126
Wiley, J. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12022-3 · Cited by 126
Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats
Wiley, J. L., Barrett, R. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00027-4 · Cited by 122
‘Hangover’ effects the morning after marijuana smoking
Chait, L. D., Fischman, M. W., & Schuster, C. R. (1985) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(85)90002-x · Cited by 107
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528
Shire, D. J., Calandra, B., Bouaboula, M., Barth, F., Rinaldi, M. L., Casellas, P., & Ferrara, P. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00285-4 · Cited by 98
Overall appraisal of the health and psychological risks of cannabis use
(1996) · Addiction · doi:10.1046/j.1360-0443.1996.9167593.x · Cited by 89
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
Piomelli, D., Giuffrida, A., Parsons, L. H., de Fonseca, F. R., & Navarro, M. A. (1999) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(99)90286-1 · Cited by 76
Tolerance to marijuana: Heart rate and subjective “high”
Nowlan, R., & Cohen, S. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977225part1550 · Cited by 73
Central mediation of the cannabinoid cue
P??rio, A., Rinaldi, M. L., Maruani, J., Barth, F., Fur, G. L., & Soubri??, P. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199601000-00006 · Cited by 68
Cannabinoid ligands and their effects on learning and performance in rhesus monkeys
Winsauer, P. J., Lambert, P. M., & Moerschbaecher, J. M. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199909000-00008 · Cited by 65
Cannabinoid/Anandamide System and Schizophrenia: Is there Evidence for Association?
Schneider, U., Leweke, F. M., Müller‐Vahl, K., & Emrich, H. M. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979355 · Cited by 43
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Pharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,511
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Clinical biomarkers in drug discovery and development
Frank, R., & Hargreaves, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1130 · Cited by 794
Self-citationIversen, L. (2003) · Brain · doi:10.1093/brain/awg143 · Cited by 732
Metadata
- Authors
- Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2001-04-01
- Volume
- 58
- Issue
- 4
- Pages
- 322
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2091638846
- Cited by
- 481
- References
- 43
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.